Profile data is unavailable for this security.
About the company
Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.
- Revenue in SEK (TTM)3.34m
- Net income in SEK-26.55m
- Incorporated2012
- Employees17.00
- LocationFluicell ABFlojelbergsgatan 8CMOELNDAL 431 37SwedenSWE
- Phone+46 313607481
- Websitehttps://fluicell.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eurocine Vaccines AB | 5.00k | -15.06m | 15.35m | 3.00 | -- | -- | -- | 3,070.54 | -0.1472 | -0.1472 | 0.00005 | -0.0018 | 0.0007 | -- | 0.002 | -- | -199.76 | -83.17 | -323.19 | -97.89 | -199,780.00 | -- | -301,180.00 | -- | -- | -- | -- | -- | -- | -- | 8.95 | -- | -- | -- |
| Circio Holding ASA | 122.38k | -110.18m | 18.15m | 11.00 | -- | -- | -- | 148.33 | -16.75 | -16.75 | 0.0181 | -12.89 | 0.0019 | -- | 0.0072 | 11,181.82 | -172.29 | -46.58 | -- | -53.40 | -- | -- | -90,029.27 | -6,902.00 | -- | -9.82 | 7.73 | -- | -98.77 | 35.43 | 74.42 | -- | -- | -- |
| Peptonic Medical AB | 37.12m | -42.59m | 20.57m | 38.00 | -- | 0.273 | -- | 0.5541 | -0.0362 | -0.0362 | 0.0326 | 0.0491 | 0.3857 | 1.32 | -- | 976,789.50 | -44.25 | -46.02 | -67.60 | -60.85 | 43.90 | 54.26 | -114.74 | -139.38 | 0.7771 | -29.32 | 0.0912 | -- | -14.93 | 149.65 | -15.55 | -- | 14.43 | -- |
| Cyxone AB | 0.00 | -22.99m | 20.77m | 4.00 | -- | 0.5332 | -- | -- | -0.1902 | -0.1902 | 0.00 | 0.1804 | 0.00 | -- | -- | -- | -47.81 | -66.19 | -53.03 | -72.35 | -- | -- | -- | -- | -- | -- | 0.0216 | -- | -- | -- | 45.87 | -- | -12.69 | -- |
| Asarina Pharma AB (publ) | 0.00 | -12.91m | 21.60m | -- | -- | 13.82 | -- | -- | -0.5704 | -0.5704 | 0.00 | 0.069 | 0.00 | -- | -- | -- | -113.04 | -61.28 | -150.47 | -71.81 | -- | -- | -- | -- | -- | -- | 0.3902 | -- | -- | -- | 2.79 | -- | -- | -- |
| Lidds AB | 0.00 | -40.21m | 21.83m | 2.00 | -- | 0.7855 | -- | -- | -0.7253 | -0.7253 | 0.00 | 0.2037 | 0.00 | -- | -- | 0.00 | -184.53 | -46.33 | -274.92 | -51.61 | -- | -- | -- | -3,076.68 | -- | -- | -- | -- | -100.00 | -- | -9.08 | -- | -- | -- |
| Redwood Pharma AB | 0.00 | -13.60m | 29.51m | 1.00 | -- | 0.4365 | -- | -- | -5.87 | -5.87 | 0.00 | 3.18 | 0.00 | -- | -- | 0.00 | -106.53 | -95.03 | -121.24 | -123.04 | -- | -- | -- | -- | -- | -19.12 | 0.00 | -- | -- | -- | -8.78 | -- | -5.11 | -- |
| Fluicell AB | 3.34m | -26.55m | 30.15m | 17.00 | -- | 25.28 | -- | 9.03 | -0.2201 | -0.2201 | 0.0282 | 0.0036 | 0.1624 | 0.6813 | 3.84 | 196,352.90 | -129.20 | -87.55 | -222.48 | -126.02 | 52.07 | 72.97 | -795.51 | -650.23 | 0.5001 | -- | 0.00 | -- | 2.68 | 22.18 | -22.90 | -- | -- | -- |
| Elicera Therapeutics AB | 11.23m | -16.40m | 31.86m | 2.00 | -- | 1.10 | -- | 2.84 | -0.8289 | -0.8289 | 0.5677 | 0.8291 | 0.2936 | -- | 8.13 | 5,615,030.00 | -42.88 | -40.06 | -66.66 | -49.74 | -- | -- | -146.02 | -415.41 | -- | -- | 0.00 | -- | 777.23 | -- | 15.64 | -- | -- | -- |
| Klaria Pharma Holding AB (publ) | 0.00 | -18.39m | 32.06m | 5.00 | -- | 0.7794 | -- | -- | -0.1824 | -0.355 | 0.00 | 0.3862 | 0.00 | -- | -- | 0.00 | -19.03 | -37.28 | -31.28 | -51.56 | -- | -- | -- | -2,077.34 | -- | -3.88 | 0.00 | -- | -100.00 | -- | 71.17 | -- | -- | -- |
| Lipigon Pharmaceuticals AB | 16.41m | -12.13m | 35.27m | -- | -- | 1.24 | -- | 2.15 | -0.4662 | -0.4662 | 0.3201 | 0.225 | 0.7388 | -- | 14.81 | -- | -54.60 | -314.67 | -75.05 | -426.49 | -- | -- | -73.91 | -488.14 | -- | -- | 0.00 | -- | -- | 444.44 | 67.83 | -- | -- | -- |
| Modus Therapeutics Holding AB | 0.00 | -17.90m | 36.84m | 2.00 | -- | 2.08 | -- | -- | -1.04 | -1.04 | 0.00 | 0.492 | 0.00 | -- | -- | 0.00 | -114.31 | -141.06 | -237.09 | -278.44 | -- | -- | -- | -- | -- | -10.96 | 0.00 | -- | -- | -- | 2.31 | -- | -- | -- |
| Gabather AB | 0.00 | -9.44m | 38.72m | -- | -- | 64.69 | -- | -- | -0.652 | -0.652 | 0.00 | 0.0331 | 0.00 | -- | -- | -- | -133.71 | -56.57 | -480.99 | -67.36 | -- | -- | -- | -17,298,800.00 | -- | -- | -- | -- | -- | -- | -10.40 | -- | -- | -- |
| Diagonal Bio AB | 23.00k | -11.68m | 41.93m | 4.00 | -- | 0.1916 | -- | 1,823.07 | -0.1982 | -0.1982 | 0.0004 | 0.3221 | 0.0007 | -- | 2.00 | 5,750.00 | -37.35 | -- | -44.49 | -- | -41,604.35 | -- | -50,769.57 | -- | 0.5105 | -104.20 | -- | -- | -88.67 | -- | 27.75 | -- | -- | -- |
| NextCell Pharma AB | 12.45m | -39.37m | 43.66m | -- | -- | 0.7819 | -- | 3.51 | -1.15 | -1.15 | 0.3621 | 1.62 | 0.1406 | 14.06 | 7.20 | -- | -44.45 | -34.92 | -50.09 | -37.06 | 12.04 | -68.21 | -316.25 | -538.60 | 4.36 | -- | 0.00 | -- | 80.96 | 72.85 | -15.21 | -- | -- | -- |
Data as of May 07 2024. Currency figures normalised to Fluicell AB's reporting currency: Swedish Krona SEK
